MicroRNA-93 通过调控细胞周期通路中多个基因的表达来控制后肢缺血后的灌流恢复。
MicroRNA-93 controls perfusion recovery after hindlimb ischemia by modulating expression of multiple genes in the cell cycle pathway.
机构信息
Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA 22908, USA.
出版信息
Circulation. 2013 Apr 30;127(17):1818-28. doi: 10.1161/CIRCULATIONAHA.112.000860. Epub 2013 Apr 4.
BACKGROUND
MicroRNAs are key regulators of gene expression in response to injury, but there is limited knowledge of their role in ischemia-induced angiogenesis, such as in peripheral arterial disease. Here, we used an unbiased strategy and took advantage of different phenotypic outcomes that follow surgically induced hindlimb ischemia between inbred mouse strains to identify key microRNAs involved in perfusion recovery from hindlimb ischemia.
METHODS AND RESULTS
From comparative microRNA profiling between inbred mouse strains that display profound differences in their extent of perfusion recovery after hindlimb ischemia, we found that the mouse strain with higher levels of microRNA-93 (miR-93) in hindlimb muscle before ischemia and the greater ability to upregulate miR-93 in response to ischemia had better perfusion recovery. In vitro, overexpression of miR-93 attenuated hypoxia-induced apoptosis in both endothelial and skeletal muscle cells and enhanced proliferation in both cell types. In addition, miR-93 overexpression enhanced endothelial cell tube formation. In vivo, miR-93 overexpression enhanced capillary density and perfusion recovery from hindlimb ischemia, and antagomirs to miR-93 attenuated perfusion recovery. Both in vitro and in vivo modulation of miR-93 resulted in alterations in the expression of >1 cell cycle pathway gene in 2 different cell types.
CONCLUSIONS
Our data indicate that miR-93 enhances perfusion recovery from hindlimb ischemia by modulation of multiple genes that coordinate the functional pathways of cell proliferation and apoptosis. Thus, miR-93 is a strong potential target for pharmacological modulation to promote angiogenesis in ischemic tissue.
背景
微小 RNA 是基因表达在应对损伤时的关键调节因子,但它们在缺血诱导的血管生成中的作用,如在外周动脉疾病中的作用,知之甚少。在这里,我们使用了一种无偏见的策略,并利用不同的表型结果,这些结果是在同种系小鼠中手术后诱导的后肢缺血之间发生的,以鉴定参与后肢缺血从后肢缺血中恢复灌注的关键微小 RNA。
方法和结果
从在同种系小鼠之间进行的比较微小 RNA 谱分析中,这些小鼠在缺血后灌注恢复程度上存在显著差异,我们发现,在缺血前后肢肌肉中微小 RNA-93(miR-93)水平较高、并且在缺血后更能上调 miR-93 的小鼠品系,其灌注恢复更好。在体外,miR-93 的过表达可减轻缺氧诱导的内皮细胞和骨骼肌细胞凋亡,并增强这两种细胞类型的增殖。此外,miR-93 的过表达增强了内皮细胞管状形成。在体内,miR-93 的过表达增强了毛细血管密度和后肢缺血的灌注恢复,而 miR-93 的反义寡核苷酸则减弱了灌注恢复。miR-93 的体外和体内调节都导致了 2 种不同细胞类型中超过 1 个细胞周期途径基因的表达改变。
结论
我们的数据表明,miR-93 通过调节多个基因来增强后肢缺血的灌注恢复,这些基因协调细胞增殖和凋亡的功能途径。因此,miR-93 是一种强大的潜在药物调节靶点,可促进缺血组织中的血管生成。
相似文献
Arterioscler Thromb Vasc Biol. 2015-5
Arterioscler Thromb Vasc Biol. 2015-9-17
J Am Heart Assoc. 2021-8-17
Arterioscler Thromb Vasc Biol. 2017-5
引用本文的文献
J Am Heart Assoc. 2024-12-3
Arterioscler Thromb Vasc Biol. 2024-8
Antioxidants (Basel). 2024-5-27
Front Cardiovasc Med. 2023-4-17
本文引用的文献
Mol Cell. 2011-6-10
J Cell Biol. 2011-1-3
Oncogene. 2010-10-18